Nantahala Capital Management Fully Exits Position in Edesa Biotech, Inc. (EDSA)

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, filed a Schedule 13G/A on May 15, 2026, regarding their holdings in Edesa Biotech, Inc. (EDSA). The filing indicates that as of the event date of March 31, 2026, the reporting persons have completely exited their position in the company. The reporting persons now beneficially own 0 shares, representing a 0.00% ownership stake in Edesa Biotech's common shares. This is an amendment to their previous filing and confirms that they no longer hold a significant position in the issuer. The shares were previously held through funds and separately managed accounts under Nantahala's control. The filing was made under Rule 13d-1(b), certifying that the securities were held in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The principal business office for the reporting persons is located in New Canaan, Connecticut.